FDA Orange Book · active-ingredient family
Desvenlafaxine fumarate
Desvenlafaxine fumarate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DESVENLAFAXINE · NDA 205583
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DESVENLAFAXINERLD×2 | SUN PHARM | NDA 205583 | — | Jan 28, 2014 | |
| DESVENLAFAXINE×2 | TEVA PHARMS USA | NDA 205208 | — | Oct 11, 2013 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Desvenlafaxine fumarate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

